Organon Second Quarter 2023 Earnings GANON™ Cautionary Note Regarding Forward-Looking Statements Disclaimer statement, cont. See Slides 21-26 of this presentation for a reconciliation of non-GAAP measures. • Adjusted EBITDA of $530 million • Adjusted EBITDA margin guidance range raised to 31.5%-33.0% Disclaimer statement Risks and uncertainties include, but are not limited to, an inability to fully execute on our product development and commercialization plans within the United States or internationally; ch ...